• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records.真实世界证据与随机对照试验:基于电子病历的临床研究。
J Korean Med Sci. 2018 Jun 26;33(34):e213. doi: 10.3346/jkms.2018.33.e213. eCollection 2018 Aug 20.
2
Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?真实世界数据中复制随机对照试验:可能会出什么问题?
Value Health. 2021 Jan;24(1):112-115. doi: 10.1016/j.jval.2020.09.015. Epub 2020 Nov 20.
3
Proceed with Caution When Using Real World Data and Real World Evidence.使用真实世界数据和真实世界证据时要谨慎。
J Korean Med Sci. 2019 Jan 16;34(4):e28. doi: 10.3346/jkms.2019.34.e28. eCollection 2019 Jan 28.
4
Translational hurdles with cannabis medicines.大麻药物转化的障碍。
Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1325-1330. doi: 10.1002/pds.4999. Epub 2020 Apr 12.
5
Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies.为真实世界证据生成可分析数据:利用先进信息学技术驾驭电子健康记录的教程。
J Med Internet Res. 2023 May 25;25:e45662. doi: 10.2196/45662.
6
Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.基于真实世界证据的非随机研究模拟随机对照试验:RCT DUPLICATE 计划的初步结果。
Circulation. 2021 Mar 9;143(10):1002-1013. doi: 10.1161/CIRCULATIONAHA.120.051718. Epub 2020 Dec 17.
7
Digital Health and Big Data Analytics: Implications of Real-World Evidence for Clinicians and Policymakers.数字健康与大数据分析:真实世界证据对临床医生和政策制定者的影响。
Int J Environ Res Public Health. 2022 Jul 8;19(14):8364. doi: 10.3390/ijerph19148364.
8
The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.真实世界证据试验在医疗保健决策中的作用不断扩大。
J Diabetes Sci Technol. 2020 Jan;14(1):174-179. doi: 10.1177/1932296819832653. Epub 2019 Mar 6.
9
[Real-world evidence : Benefits and limitations in multiple sclerosis research].[真实世界证据:多发性硬化症研究中的益处与局限性]
Nervenarzt. 2017 Oct;88(10):1153-1158. doi: 10.1007/s00115-017-0387-y.
10
Use of real-world evidence for oncology clinical decision making in emerging economies.新兴经济体中使用真实世界证据进行肿瘤学临床决策。
Future Oncol. 2021 Aug;17(22):2951-2960. doi: 10.2217/fon-2021-0425. Epub 2021 May 28.

引用本文的文献

1
An assessment of anti-VEGF drugs safety based on real-world data: from popularity to spontaneous reporting in eudravigilance database.基于真实世界数据的抗VEGF药物安全性评估:从流行情况到药物警戒数据库中的自发报告
Graefes Arch Clin Exp Ophthalmol. 2025 Aug 15. doi: 10.1007/s00417-025-06895-6.
2
Leveraging BERT for embedding ICD codes from large scale cardiovascular EMR data to understand patient diagnostic patterns.利用BERT从大规模心血管电子病历数据中嵌入ICD编码,以了解患者的诊断模式。
BMC Med Inform Decis Mak. 2025 Aug 11;25(1):300. doi: 10.1186/s12911-025-03145-x.
3
Why High-Volume Post-Dilution Hemodiafiltration Should Be the New Standard in Dialysis Care: A Comprehensive Review of Clinical Outcomes and Mechanisms.为何高容量后稀释血液滤过应成为透析治疗的新标准:临床结局与机制的全面综述
J Clin Med. 2025 Jul 9;14(14):4860. doi: 10.3390/jcm14144860.
4
Data mining and safety analysis of FGFR tyrosine kinase inhibitors based on the FAERS database.基于FAERS数据库的FGFR酪氨酸激酶抑制剂的数据挖掘与安全性分析
Sci Rep. 2025 Jul 18;15(1):26150. doi: 10.1038/s41598-025-11411-1.
5
A real-world data analysis of montelukast in FDA Adverse Event Reporting System (FAERS) database.对美国食品药品监督管理局不良事件报告系统(FAERS)数据库中孟鲁司特的真实世界数据分析。
BMC Pharmacol Toxicol. 2025 Jul 1;26(1):130. doi: 10.1186/s40360-025-00959-3.
6
Clinical Experience With an Aragonite-Based Scaffold Implant for Knee Cartilage Repair: A Multicenter Case Series.基于文石的膝关节软骨修复支架植入的临床经验:多中心病例系列
Cureus. 2025 Jun 16;17(6):e86127. doi: 10.7759/cureus.86127. eCollection 2025 Jun.
7
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis.布地奈德/福莫特罗/格隆溴铵三联超细微固定剂量组合对慢性阻塞性肺疾病症状和肺功能的真实世界有效性:一项系统评价和荟萃分析
Int J Chron Obstruct Pulmon Dis. 2025 May 27;20:1723-1736. doi: 10.2147/COPD.S511334. eCollection 2025.
8
Application of Real-World Evidence to Support FDA Regulatory Decision Making.应用真实世界证据支持美国食品药品监督管理局的监管决策
AAPS J. 2025 May 28;27(4):98. doi: 10.1208/s12248-025-01082-1.
9
High-Volume Hemodiafiltration: Expanding the Evidence Beyond Randomized Trials-A Critical Perspective on the 2025 EuDial Consensus.高容量血液滤过:拓展随机试验之外的证据——对2025年欧洲透析共识的批判性观点
J Clin Med. 2025 May 3;14(9):3174. doi: 10.3390/jcm14093174.
10
Effects of Different Gonadotropin-Releasing Hormone Agonists on IVF/ICSI-ET Outcomes in Long Protocol: A Retrospective Study.长效方案中不同促性腺激素释放激素激动剂对体外受精/卵胞浆内单精子注射-胚胎移植结局的影响:一项回顾性研究
Int J Womens Health. 2025 May 8;17:1313-1320. doi: 10.2147/IJWH.S517738. eCollection 2025.

本文引用的文献

1
Artificial Intelligence and Machine Learning in Radiology: Opportunities, Challenges, Pitfalls, and Criteria for Success.人工智能和机器学习在放射学中的应用:机遇、挑战、陷阱和成功标准。
J Am Coll Radiol. 2018 Mar;15(3 Pt B):504-508. doi: 10.1016/j.jacr.2017.12.026. Epub 2018 Feb 4.
2
The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients.根据韩国患者所开具的HMG-CoA还原酶抑制剂类型,糖尿病和糖尿病前期发病率的差异。
Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1156-1163. doi: 10.1002/pds.4237. Epub 2017 May 29.
3
Analysis of National Pharmacovigilance Data Associated with Statin Use in Korea.韩国与他汀类药物使用相关的国家药物警戒数据分析。
Basic Clin Pharmacol Toxicol. 2017 Nov;121(5):409-413. doi: 10.1111/bcpt.12808. Epub 2017 Jun 22.
4
Comparative Analysis of the Suspected Heparin-Induced Thrombocytopenia Level in Korea.韩国疑似肝素诱导的血小板减少症水平的比较分析。
Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):360-367. doi: 10.1111/bcpt.12791. Epub 2017 Aug 9.
5
Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea.根据韩国的基线低密度脂蛋白胆固醇水平对他汀类药物的成本效益进行分析和比较。
J Clin Pharm Ther. 2017 Jun;42(3):292-300. doi: 10.1111/jcpt.12512. Epub 2017 Mar 1.
6
Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans.韩国人基线低密度脂蛋白胆固醇水平高于190mg/dL时使用中等强度他汀类药物的情况。
Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):272-278. doi: 10.1111/bcpt.12765. Epub 2017 Jul 9.
7
Comparative analysis of the efficacy of low- and moderate-intensity statins in Korea.韩国低强度和中等强度他汀类药物疗效的比较分析。
Int J Clin Pharmacol Ther. 2016 Nov;54(11):864-871. doi: 10.5414/CP202332.
8
Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea.韩国ω-3脂肪酸治疗高甘油三酯血症疗效的比较分析。
J Clin Pharm Ther. 2016 Oct;41(5):508-14. doi: 10.1111/jcpt.12423. Epub 2016 Jul 18.
9
Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea.韩国实际临床中他汀类药物相关转氨酶升高与基线转氨酶水平的关系
J Clin Pharm Ther. 2016 Jun;41(3):266-72. doi: 10.1111/jcpt.12377. Epub 2016 Mar 25.
10
Analysis and comparison of statin prescription patterns and outcomes according to clinical department.根据临床科室对他汀类药物处方模式及治疗结果进行分析与比较。
J Clin Pharm Ther. 2016 Feb;41(1):70-7. doi: 10.1111/jcpt.12350. Epub 2016 Jan 21.

真实世界证据与随机对照试验:基于电子病历的临床研究。

Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records.

机构信息

Department of Medical Informatics, The Catholic University of Korea College of Medicine, Seoul, Korea.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2018 Jun 26;33(34):e213. doi: 10.3346/jkms.2018.33.e213. eCollection 2018 Aug 20.

DOI:10.3346/jkms.2018.33.e213
PMID:30127705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6097073/
Abstract

Real-world evidence (RWE) and randomized control trial (RCT) data are considered mutually complementary. However, compared with RCT, the outcomes of RWE continue to be assigned lower credibility. It must be emphasized that RWE research is a real-world practice that does not need to be executed as RCT research for it to be reliable. The advantages and disadvantages of RWE must be discerned clearly, and then the proper protocol can be planned from the beginning of the research to secure as many samples as possible. Attention must be paid to privacy protection. Moreover, bias can be reduced meaningfully by reducing the number of dropouts through detailed and meticulous data quality management. RCT research, characterized as having the highest reliability, and RWE research, which reflects the actual clinical aspects, can have a mutually supplementary relationship. Indeed, once this is proven, the two could comprise the most powerful evidence-based research method in medicine.

摘要

真实世界证据(RWE)和随机对照试验(RCT)数据被认为是相互补充的。然而,与 RCT 相比,RWE 的结果仍然被赋予较低的可信度。必须强调的是,RWE 研究是一种真实世界的实践,不需要像 RCT 研究那样执行,它才是可靠的。必须清楚地辨别 RWE 的优缺点,然后从研究开始就制定适当的方案,以确保尽可能多的样本。必须注意隐私保护。此外,通过详细和细致的数据质量管理,减少大量的脱落,可显著减少偏差。RCT 研究具有最高的可靠性,而反映实际临床方面的 RWE 研究,可以具有相互补充的关系。事实上,一旦证明了这一点,两者就可以构成医学中最强大的基于证据的研究方法。